Weight management medication may be considered for adults with obesity or certain adults who are overweight and also have weight-related health concerns
Mounjaro's dual GIP/GLP-1 mechanism may confer additional metabolic benefits, though long-term comparative effectiveness studies are ongoing
Tirzepatide is a once-weekly subcutaneous injection approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
Be Creative In Your Exercise If you use the same exercise routine all the time, your body gets used to it and figures out how to perform the same way but while burning fewer calories
1 2 US patent 9474780, Bokvist BK, Coskun T, Cummins RC, Alsina-Fernandez J, "GIP and GLP-1 co-agonist compounds", issued 25 October 2016, assigned to Eli Lilly and Co al